<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Marrella, Veronica</dc:creator>
  <dc:creator>Poliani, Pietro Luigi</dc:creator>
  <dc:creator>Notarangelo, Luigi Daniele</dc:creator>
  <dc:creator>Grassi, Fabio</dc:creator>
  <dc:creator>Villa, Anna</dc:creator>
  <dc:date>2014-06-02</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Thymocytes and thymic epithelial cells (TECs) cross-talk is essential to support T cell  development and preserve thymic architecture and maturation of TECs and Foxp3+  natural regulatory T cells. Accordingly, disruption of thymic lymphostromal cross-talk  may have major implications on the thymic mechanisms that govern T cell tolerance.  Several genetic defects have been described in humans that affect early stages of T cell  development [leading to severe combined immune deficiency (SCID)] or late stages in  thymocyte maturation (resulting in combined immunodeficiency). Hypomorphic  mutations in SCID-causing genes may allow for generation of a limited pool of T  lymphocytes with a restricted repertoire. These conditions are often associated with  infiltration of peripheral tissues by activated T cells and immune dysregulation, as best  exemplified by Omenn syndrome (OS). In this review, we will discuss our recent findings  on abnormalities of thymic microenvironment in OS with a special focus of defective  maturation of TECs, altered distribution of thymic dendritic cells and impairment of  deletional and non-deletional mechanisms of central tolerance. Here, taking advantage  of mouse models of OS and atypical SCID, we will discuss how modifications in stromal  compartment impact and shape lymphocyte differentiation, and vice versa how  inefficient T cell signaling results in defective stromal maturation. These findings are  instrumental to understand the extent to which novel therapeutic strategies should act  on thymic stroma to achieve full immune reconstitution.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://susi.usi.ch/global/documents/319035</dc:identifier>
  <dc:identifier>https://n2t.net/ark:/12658/srd1319035</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/319035/files/Marrella_FI_2014.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.3389/fimmu.2014.00259</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1319035</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY</dc:rights>
  <dc:source>Frontiers in immunology. - 2014, vol. 5, p. 259</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Thymus</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Rag deficiency</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Omenn and leaky SCID models</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Central tolerance</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Thymic reconstitution</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">Thymic cross-talk</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/57</dc:subject>
  <dc:title xmlns:ns7="xml" ns7:lang="en">Rag defects and thymic stroma : lessons from animal models</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
